Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-156-3 | CAS number: 32687-78-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 1983 - August 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Version / remarks:
- (1981)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- QAU statement available, no GLP compliance statement available
- Limit test:
- no
Test material
- Reference substance name:
- 2',3-bis[[3-[3,5-di-tert-butyl-4-hydroxyphenyl]propionyl]]propionohydrazide
- EC Number:
- 251-156-3
- EC Name:
- 2',3-bis[[3-[3,5-di-tert-butyl-4-hydroxyphenyl]propionyl]]propionohydrazide
- Cas Number:
- 32687-78-8
- Molecular formula:
- C34H52N2O4
- IUPAC Name:
- 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N'-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]propanehydrazide
- Details on test material:
- - Physical state: solid
- Analytical purity: 100%
- Stability under test conditions: Determined by the sponsor
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley Tif: RAIf (SPF)
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Closed-breeding colony, Ciba-Geigy WST
- Age at study initiation: 2 months
- Weight at study initiation: 180-200 g
- Housing: 4 per cage throughout the experiment
- Diet: standard cube diet, NAFAG No. 890, ad libitum
- Water: tap water, ad libitum
- Acclimation period: 6 days (between allocation to the corresponding group on day 0 and the first treatment on day 6 post coitum)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21+/-2
- Humidity (%): 55+/-10
- Photoperiod: 12 hrs dark /12 hrs light (Light: 6 am-6 pm)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: water:polyethylene glycol400 (1:1)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The suspension of the test material was freshly prepared daily by homogenization and stirring (magnetic stirrer), and administered at a rate of 10 mL/kg of body weight. - Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- - Impregnation procedure: cohoused
- M/F ratio per cage: 1:3
- Length of cohabitation: overnight
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 of pregnancy - Duration of treatment / exposure:
- day 6-15 p.c.
- Frequency of treatment:
- once daily
- Duration of test:
- day 0- 21 p.c.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 3 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 24 females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
A preliminary experiment was carried out on 15 fertilized rats each for the vehicle control and the dose group (3000 mg/kg d). The test material was suspended in a mixture of distilled water and polyethylene glycol 400 (1:1) and administered orally by intubation from day 6 until day 15 of pregnancy, inclusive. Treatment at this 3000 mg/kg dose level caused no depression in either food consumption or body-weight gain of the mother animals. Apart from a reduced body weight no adverse effects were recorded for the progeny at sacrifice shortly before term in comparison with the vehicle control. On the basis of the foregoing results the doses for the main stpdy were selected at 0, 500, 1500 and 3000 mg/kg of body weight
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: daily
FOOD CONSUMPTION:
- On day 6, 11, 16, 21.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: ovaries and uterus (mucosa and contents, including amniotic fluid and placentae as well as abortions and resorption sites) - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No
- Number of corpora lutea: No
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: Yes: 1/3 per litter
- Skeletal examinations: Yes: 2/3 per litter
- Head examinations: No data - Statistics:
- Average weight: Student's t test, one-tailed
Records of reproduction data:
The numbers of embryonic and/or foetal deaths (resorptions): Chi-Square-test, Yates' correction - Historical control data:
- Historical cumulative control (1977-1983) of reproduction data and anomalies and malformations provided.
Historical cumulative control of visceral examination provided.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- With regard to the vehicle control and in accordance with the results of the preliminary experiment, neither food consumption nor body-weight gain was altered in the experimental groups.
Female No. 78 (3000 mg/kg d) died spontaneously on day 7 p.c. (i.e. after one application) likely in consequence of an intubation error.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 3 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: No adverse effects recorded
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- The pregnancy rates expressed as average number ot implantation sites per female were comparable for all groups in the present experiment. The numbers of embryonic and/or foetal deaths (resorptions) were not increased at either dose.
The male to female ratios of the foetuses were also comparable for all groups. In comparison with the vehicle control, the average body-weight of the live foetuses was not diminished at either dose. Fusion of placentas, the implantation sites consisting of a embryonic resorption and a poorly developed male foetus, respectively, was noted for one female (No. 48) of the 500 mg/kg group.
The gross inspection of the live foetuses revealed one foetus with omphalocele in the low-dose group. Carrying out the slicing technique for "visceral" examination, dilatation of the renal pelvis (unilateral) was found in one foetus of the vehicle control. These instances are considered to be of a spontaneous origin and not related to the treatment.
The skeletal assessment revealed instances of irregular sternebral ossification in the dose groups and in the vehicle control; abnormal "wide suture" was found in one foetus of the high-dose group, in addition. Concerning the status of skeletal maturation of the foetuses shortly before term, a slight delay in ossification of the phalangeal nuclei of the hind-limbs was recorded for the high-dose group in comparison with the vehicle control; this finding, however, is not assumed to be of experimental significance.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 3 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects recorded
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 1: Summarized reproduction data of the main study.
Dose group (mg/kg d) |
0 |
500 |
1500 |
3000 |
Historical control data (range) |
Spontaneous deaths |
0/24 |
0/24 |
0/24 |
1/24 |
0/858 |
Body-weight gain (%) |
+14.6 |
+13.3 |
+16.7 |
+13.9 |
|
Females with deciduomata |
0/24 |
0/24 |
0/24 |
0/23 |
1/858 |
Females with implantations |
22/24 |
22/24 |
23/24 |
20/23 |
800/858 |
Implantations/female (mean, SD) |
15.9±2.5 |
16.3±1.5 |
15.4±1.9 |
16.1±1.8 |
13.14±2.36 |
Females with total abortion |
0 |
0 |
0 |
0 |
0/800 |
Females with partial abortion |
0 |
0 |
0 |
0 |
2/800 |
Embryonal deaths (resorptions) |
6.3 |
4.2 |
6.5 |
8.4 |
8.71 |
Foetal deaths (resorptions) |
0 |
0.3 |
0 |
0 |
0.28 |
Dead foetuses |
0 |
0 |
0 |
0 |
0.12 |
Number of live foetuses (males-females) |
163-165 |
158-185 |
164-167 |
150-144 |
4662- 4888 |
Percent males of live foetuses |
49.7 |
46.1 |
49.5 |
51.0 |
48.8 |
Average weight of live foetuses |
5.4±0.4 |
5.3±0.5 |
5.4±0.5 |
5.4±0.5 |
5.34±0.45 |
Table 2: Summarized data of skeletal assessment of the foetuses (in percent).
Dose group (mg/kg d) |
0 |
500 |
1500 |
3000 |
Historical control data (range) |
Number of skeletons examined |
219 |
229 |
222 |
195 |
6180 |
Phalangeal nuclei (a): Fore-limb |
14.6 |
21.0 |
10.4 |
9.2 |
0-10.7 |
Phalangeal nuclei (a): Hind-limb |
45.2 |
50.2 |
50.5 |
55.4 |
4.5-65.6 |
Calcaneus |
89.5 |
86.9 |
91.0 |
93.8 |
6.8-90.3 |
5thsternebra (c) |
15.1 |
14.4 |
20.3 |
9.7 |
3.0-88.3 |
Vertebrae (d) |
1.4 |
1.7 |
3.2 |
3.6 |
0-6.9 |
Vertebrae (e) |
0.0 |
0.4 |
1.4 |
0.5 |
0.23 |
Skeletal anomalies |
0.9 |
2.2 |
1.4 |
1.5 |
0.52 |
(a) Ossification still absent in proximal phalanges, digit 5
(b) Ossification still absent
(c) Still incompletely ossified
(d) Some thoracic vertebral centres still dumbbell-shaped
(e) Some thoracic vertebral centres bipartite
Applicant's summary and conclusion
- Conclusions:
- The test substance was devoid of an enbryotoxic potential and did not reveal teratogenic potency in the rat under the present experimental conditions.
- Executive summary:
A developmental toxicity/teratogenicity study according OECD TG 414 was performed (Ciba-Geigy, 1983). 24 female rats were mated, and treated with 500, 1500, and 3000 mg test substance/kg body weight once daily on day 6 -15 p.c. On gestation day 21 the animals were sacrificed. Dams were observed for clinical signs, behavior, body weight and food consumption. After sacrifice ovaries and uterus (mucosa and contents, including amniotic fluid and placentae as well as abortions and resorption sites) were examined. In the fetuses external examinations, soft tissue examinations, and skeletal examinations were conducted. Neither food consumption nor body-weight gain was altered in the experimental groups. The pregnancy rates expressed as average number of implantation sites per female were comparable for all groups in the present experiment. The numbers of embryonic and/or fetal deaths (resorptions) were not increased at either dose. The male to female ratios of the fetuses were also comparable for all groups. In comparison with the vehicle control, the average body-weight of the live fetuses was not diminished at either dose. The gross inspection of the live fetuses revealed one fetus with omphalocele in the low-dose group. Dilatation of the renal pelvis (unilateral) was found in one fetus of the vehicle control. The skeletal assessment revealed instances of irregular sternebral ossification in the dose groups and in the vehicle control; abnormal" wide suture" was found in one fetus of the high-dose group, in addition. Concerning the status of skeletal maturation of the fetuses shortly before term, a slight delay in ossification of the phalangeal nuclei of the hind-limbs was recorded for the high-dose group in comparison with the vehicle control; this finding, however, is not assumed to be of experimental significance.
In summary, the test article was devoid of an embryotoxic activity and did not reveal teratogenic potency in the rat under the present experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.